SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 226 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,985 | +34.3% | 459 | +131.8% | 0.00% | – |
| Q1 2024 | $3,711 | -13.5% | 198 | 0.0% | 0.00% | – |
| Q4 2023 | $4,291 | -25.0% | 198 | -28.8% | 0.00% | -100.0% |
| Q3 2023 | $5,721 | +90.1% | 278 | +334.4% | 0.00% | – |
| Q2 2023 | $3,009 | +37.9% | 64 | +23.1% | 0.00% | – |
| Q1 2023 | $2,182 | +2.2% | 52 | -7.1% | 0.00% | – |
| Q4 2022 | $2,136 | -76.3% | 56 | -76.0% | 0.00% | -100.0% |
| Q3 2022 | $9,000 | +350.0% | 233 | +219.2% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 73 | +32.7% | 0.00% | -100.0% |
| Q3 2021 | $2,000 | 0.0% | 55 | +37.5% | 0.00% | – |
| Q2 2021 | $2,000 | -50.0% | 40 | -23.1% | 0.00% | -100.0% |
| Q1 2021 | $4,000 | 0.0% | 52 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | +33.3% | 52 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | +50.0% | 52 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
| Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
| EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
| New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
| AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
| APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
| OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
| Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |